CA 19-9
Price range: $270.00 through $1,055.00
Description
Product Description
CA 19-9, a carbohydrate antigenic determinant identified as a sialylated lactoN-fucopentose II, is related to the Lewis blood group.15 The CA 19-9 antibody has been shown to label adenocarcinomas of the pancreas, stomach, colon and gall bladder. CA 19-9 is also expressed in primary and metastatic ovarian carcinomas.16-18
Specifications
Specifications
| Weight | N/A |
|---|---|
| Dimensions | N/A |
| Intended Use | |
| Species Reactivity | |
| Source | |
| Clone | |
| Isotype | |
| Antigen | |
| Localization | |
| Positive Control |
Datasheets & SDS
| Download CE Marked IVD Datasheet |
| Download IVD Datasheet Without CE Mark |
| Download RUO Data Sheet |
| Download SDS Sheet |
Browse more documents for this product (IFUs, datasheets, translations, SDS, and more).
References
1. Kelly PJ, et al. J Clin Pathol. 2010 Feb; 63(2):169-73.
2. Nakao A, et al. Semin Surg Oncol. 1998 Jul-Aug; 15(1):15-22.
3. Nakayama T, et al. J Surg Oncol. 1997 Dec; 66(4):238-43.
![(L) Anaplastic large cell lymphoma and (R) Lung adenocarcinoma stained with ALK antibody [5A4]](https://biocare.net/wp-content/uploads/3041-247x296.jpg)
